Use of DermTech Stratum in clinical trials can help make this possible by enabling remote and non-invasive skin sample collection.  

Technology can help decentralize clinical trials, leading to greater patient satisfaction, a more diverse patient population, better retention and cost savings, according to a presentation by

DermTech at Outsourcing in Clinical Trials Southern California, held from Sept. 28-29 in San Diego. 

Elisa Lanni, M.S., DermTech Stratum senior project manager, discussed the current challenges of patient recruitment and retention in clinical trials and how hybridization and decentralization can bridge the gap to create a better patient experience. The presentation, titled “Technological Advances in Clinical Trials – Exploring the Value of Decentralization,” emphasized how the traditional approach to clinical trials can be inconvenient and inaccessible for patients, leading to lesser quality data.

A potential solution enabled by DermTech Stratum reevaluates clinical trial design to consider the post-pandemic climate and how virtual or hybrid models have become the norm across work and healthcare settings. She elaborated on the benefits, risks and outcomes of using technology to decentralize clinical trials, which ultimately leads to greater patient satisfaction, a more diverse patient population, better retention and cost savings. Finally, she expanded on the role of DermTech Stratum, DermTech’s translational medicine service offering, in clinical trials. By leveraging DermTech’s  Smart Sticker, DermTech Stratum enables remote and non-invasive skin sample collection.  

“We are honored to have been a part of Outsourcing in Clinical Trials Southern California to share our perspective on the new wave of decentralization in clinical trials and how this will ultimately improve the patient experience,” says Lanni in a news release. “Without patients, we have no data. We must put innovative technology at the forefront of our approach to dermatological research and development.”

Listen to her talk here.